These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22307331)

  • 1. The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis.
    Bosdou JK; Venetis CA; Kolibianakis EM; Toulis KA; Goulis DG; Zepiridis L; Tarlatzis BC
    Hum Reprod Update; 2012; 18(2):127-45. PubMed ID: 22307331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of transdermal testosterone in poor responders undergoing IVF: systematic review and meta-analysis.
    González-Comadran M; Durán M; Solà I; Fábregues F; Carreras R; Checa MA
    Reprod Biomed Online; 2012 Nov; 25(5):450-9. PubMed ID: 22999555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis.
    Sunkara SK; Pundir J; Khalaf Y
    Reprod Biomed Online; 2011 Jun; 22(6):545-55. PubMed ID: 21493151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgens and diminished ovarian reserve: the long road from basic science to clinical implementation. A comprehensive and systematic review with meta-analysis.
    Neves AR; Montoya-Botero P; Polyzos NP
    Am J Obstet Gynecol; 2022 Sep; 227(3):401-413.e18. PubMed ID: 35364061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: a systematic review and network meta-analysis.
    Zhang Y; Zhang C; Shu J; Guo J; Chang HM; Leung PCK; Sheng JZ; Huang H
    Hum Reprod Update; 2020 Feb; 26(2):247-263. PubMed ID: 32045470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal testosterone pretreatment in poor responders undergoing ICSI: a randomized clinical trial.
    Bosdou JK; Venetis CA; Dafopoulos K; Zepiridis L; Chatzimeletiou K; Anifandis G; Mitsoli A; Makedos A; Messinis IE; Tarlatzis BC; Kolibianakis EM
    Hum Reprod; 2016 May; 31(5):977-85. PubMed ID: 26956551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Luteinizing Hormone supplementation in poor responders undergoing IVF: a systematic review and meta-analysis.
    Fan W; Li S; Chen Q; Huang Z; Ma Q; Wang Y
    Gynecol Endocrinol; 2013 Apr; 29(4):278-84. PubMed ID: 23347045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mid-follicular phase recombinant LH versus urinary HCG supplementation in poor ovarian responders undergoing IVF - a prospective double-blinded randomized study.
    Mak SM; Wong WY; Chung HS; Chung PW; Kong GW; Li TC; Cheung LP
    Reprod Biomed Online; 2017 Mar; 34(3):258-266. PubMed ID: 28063801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher live birth rate following transdermal testosterone pretreatment in poor responders: a systematic review and meta-analysis.
    Katsika ET; Bosdou JK; Goulis DG; Grimbizis GF; Kolibianakis EM
    Reprod Biomed Online; 2023 Jan; 46(1):81-91. PubMed ID: 36369150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of luteinizing hormone activity in ovarian stimulation for IVF.
    Venetis CA; Kolibianakis EM; Tarlatzi TB; Tarlatzis BC
    Reprod Biomed Online; 2009; 18 Suppl 2():31-6. PubMed ID: 19406029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders.
    Yeung TW; Chai J; Li RH; Lee VC; Ho PC; Ng EH
    Fertil Steril; 2014 Jul; 102(1):108-115.e1. PubMed ID: 24796766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial.
    Lossl K; Andersen CY; Loft A; Freiesleben NL; Bangsbøll S; Andersen AN
    Hum Reprod; 2008 Aug; 23(8):1820-9. PubMed ID: 18487212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone therapy for women with poor ovarian response undergoing IVF: a meta-analysis of randomized controlled trials.
    Noventa M; Vitagliano A; Andrisani A; Blaganje M; Viganò P; Papaelo E; Scioscia M; Cavallin F; Ambrosini G; Cozzolino M
    J Assist Reprod Genet; 2019 Apr; 36(4):673-683. PubMed ID: 30610664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Dehydroepiandrosterone (DHEA) to overcome the effect of ovarian ageing (DITTO): A proof of principle double blinded randomized placebo controlled trial.
    Narkwichean A; Maalouf W; Baumgarten M; Polanski L; Raine-Fenning N; Campbell B; Jayaprakasan K
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():39-48. PubMed ID: 28934714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study.
    Chern CU; Tsui KH; Vitale SG; Chen SN; Wang PH; Cianci A; Tsai HW; Wen ZH; Lin LT
    Reprod Biol Endocrinol; 2018 Sep; 16(1):90. PubMed ID: 30223902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).
    Kwan I; Bhattacharya S; McNeil A; van Rumste MM
    Cochrane Database Syst Rev; 2008 Apr; (2):CD005289. PubMed ID: 18425917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live birth rates after IVF are reduced by both low and high progesterone levels on the day of human chorionic gonadotrophin administration.
    Santos-Ribeiro S; Polyzos NP; Haentjens P; Smitz J; Camus M; Tournaye H; Blockeel C
    Hum Reprod; 2014 Aug; 29(8):1698-705. PubMed ID: 24939956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis.
    Kolibianakis EM; Venetis CA; Diedrich K; Tarlatzis BC; Griesinger G
    Hum Reprod Update; 2009; 15(6):613-22. PubMed ID: 19561136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.